Myung-Ju Ahn, MD

Trials

Studies that name Myung-Ju Ahn, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:40 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04967417 · Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases

  Samsung Medical Center · completed · Non-small Cell Lung Cancer · principal investigator
• Ph3
  NCT03991403 · Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

  Samsung Medical Center · unknown · Non-small Cell Lung Cancer · principal investigator
• Ph2
  NCT03778229 · Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

  AstraZeneca · active not recruiting · Carcinoma · principal investigator
• Ph2
  NCT03775486 · Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)

  AstraZeneca · active not recruiting · Non-small Cell Lung Cancer NSCLC · principal investigator
• Ph2
  NCT03050437 · A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI

  Samsung Medical Center · unknown · Carcinoma, Non-Small-Cell Lung · principal investigator
• Ph2
  NCT02558387 · Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck

  Samsung Medical Center · unknown · Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.